207 related articles for article (PubMed ID: 27061087)
1. Inhibition of fatty acid synthase is protective in pulmonary hypertension.
Singh N; Manhas A; Kaur G; Jagavelu K; Hanif K
Br J Pharmacol; 2016 Jun; 173(12):2030-45. PubMed ID: 27061087
[TBL] [Abstract][Full Text] [Related]
2. Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension.
Singh N; Shafiq M; Jagavelu K; Hanif K
Exp Cell Res; 2019 Oct; 383(2):111569. PubMed ID: 31465767
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid synthase modulates proliferation, metabolic functions and angiogenesis in hypoxic pulmonary artery endothelial cells.
Singh N; Singh H; Jagavelu K; Wahajuddin M; Hanif K
Eur J Pharmacol; 2017 Nov; 815():462-469. PubMed ID: 28974347
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of Fatty Acid Synthase in Hypoxia-Induced Pulmonary Hypertensive Mouse Energy Metabolism.
Hou C; Chen J; Zhao Y; Niu Y; Lin S; Chen S; Zong Y; Sun X; Xie L; Xiao T
Oxid Med Cell Longev; 2021; 2021():9990794. PubMed ID: 34457121
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of an inhibitor of fatty acid synthase.
Kuhajda FP; Pizer ES; Li JN; Mani NS; Frehywot GL; Townsend CA
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3450-4. PubMed ID: 10716717
[TBL] [Abstract][Full Text] [Related]
6. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion.
Clegg DJ; Wortman MD; Benoit SC; McOsker CC; Seeley RJ
Diabetes; 2002 Nov; 51(11):3196-201. PubMed ID: 12401710
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.
Kuncewitch M; Yang WL; Jacob A; Khader A; Giangola M; Nicastro J; Coppa GF; Wang P
Surgery; 2016 Feb; 159(2):570-9. PubMed ID: 26372196
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy.
Rae C; Haberkorn U; Babich JW; Mairs RJ
Radiat Res; 2015 Nov; 184(5):482-93. PubMed ID: 26484401
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
10. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
11. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.
Landree LE; Hanlon AL; Strong DW; Rumbaugh G; Miller IM; Thupari JN; Connolly EC; Huganir RL; Richardson C; Witters LA; Kuhajda FP; Ronnett GV
J Biol Chem; 2004 Jan; 279(5):3817-27. PubMed ID: 14615481
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells.
Ho TS; Ho YP; Wong WY; Chi-Ming Chiu L; Wong YS; Eng-Choon Ooi V
Biomed Pharmacother; 2007 Oct; 61(9):578-87. PubMed ID: 17904792
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib alleviates experimental pulmonary arterial hypertension.
Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
[TBL] [Abstract][Full Text] [Related]
16. Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension.
Sahara M; Sata M; Morita T; Hirata Y; Nagai R
PLoS One; 2012; 7(3):e33367. PubMed ID: 22479390
[TBL] [Abstract][Full Text] [Related]
17. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.
Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR
Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173
[TBL] [Abstract][Full Text] [Related]
18. Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions.
Shafiq M; Lone ZR; Bharati P; Mahapatra S; Rai P; Khandelwal N; Gaikwad AN; Jagavelu K; Hanif K
Pulm Pharmacol Ther; 2022 Oct; 76():102156. PubMed ID: 36030026
[TBL] [Abstract][Full Text] [Related]
19. Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension.
Masson B; Saint-Martin Willer A; Dutheil M; Penalva L; Le Ribeuz H; El Jekmek K; Ruchon Y; Cohen-Kaminsky S; Sabourin J; Humbert M; Mercier O; Montani D; Capuano V; Antigny F
Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L246-L261. PubMed ID: 37366608
[TBL] [Abstract][Full Text] [Related]
20. 3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis.
Zhang YL; Zhang R; Shen YF; Huang KY; He YY; Zhao JH; Jing ZC
Am J Hypertens; 2019 Mar; 32(4):426-432. PubMed ID: 30561502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
